Treace Medical Concepts, Inc. (TMCI)

Treace Medical Concepts Statistics

Total Valuation

TMCI has a market cap or net worth of $326.81 million. The enterprise value is $272.08 million.

Market Cap	326.81M
Enterprise Value	272.08M

Important Dates

The next confirmed earnings date is Tuesday, November 5, 2024, after market close.

Earnings Date	Nov 5, 2024
Ex-Dividend Date	n/a

Share Statistics

TMCI has 62.19 million shares outstanding. The number of shares has increased by 6.96% in one year.

Shares Outstanding	62.19M
Shares Change (YoY)	+6.96%
Shares Change (QoQ)	+0.47%
Owned by Insiders (%)	26.71%
Owned by Institutions (%)	55.39%
Float	45.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.49
Forward PS	1.36
PB Ratio	2.65
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.37
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.86, with a Debt / Equity ratio of 0.62.

Current Ratio	3.86
Quick Ratio	2.73
Debt / Equity	0.62
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-12.39

Financial Efficiency

Return on equity (ROE) is -48.60% and return on invested capital (ROIC) is -20.12%.

Return on Equity (ROE)	-48.60%
Return on Assets (ROA)	-17.02%
Return on Capital (ROIC)	-20.12%
Revenue Per Employee	$384,754
Profits Per Employee	-$123,419
Employee Count	516
Asset Turnover	0.83
Inventory Turnover	1.14

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -53.03% in the last 52 weeks. The beta is 0.24, so TMCI's price volatility has been lower than the market average.

Beta (5Y)	0.24
52-Week Price Change	-53.03%
50-Day Moving Average	5.35
200-Day Moving Average	8.49
Relative Strength Index (RSI)	51.12
Average Volume (20 Days)	412,520

Short Selling Information

The latest short interest is 4.91 million, so 7.89% of the outstanding shares have been sold short.

Short Interest	4.91M
Short Previous Month	4.93M
Short % of Shares Out	7.89%
Short % of Float	10.77%
Short Ratio (days to cover)	9.25

Income Statement

In the last 12 months, TMCI had revenue of $198.53 million and -$63.68 million in losses. Loss per share was -$1.03.

Revenue	198.53M
Gross Profit	160.16M
Operating Income	-64.79M
Pretax Income	-63.68M
Net Income	-63.68M
EBITDA	-57.90M
EBIT	-64.79M
Loss Per Share	-$1.03

Balance Sheet

The company has $95.05 million in cash and $69.85 million in debt, giving a net cash position of $25.19 million or $0.41 per share.

Cash & Cash Equivalents	95.05M
Total Debt	69.85M
Net Cash	25.19M
Net Cash Per Share	$0.41
Equity (Book Value)	112.14M
Book Value Per Share	1.80
Working Capital	127.11M

Cash Flow

In the last 12 months, operating cash flow was -$30.10 million and capital expenditures -$11.41 million, giving a free cash flow of -$41.50 million.

Operating Cash Flow	-30.10M
Capital Expenditures	-11.41M
Free Cash Flow	-41.50M
FCF Per Share	-$0.67

Margins

Gross margin is 80.67%, with operating and profit margins of -32.63% and -32.08%.

Gross Margin	80.67%
Operating Margin	-32.63%
Pretax Margin	-32.08%
Profit Margin	-32.08%
EBITDA Margin	-29.17%
EBIT Margin	-32.63%
FCF Margin	-20.91%

Dividends & Yields

TMCI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.96%
Shareholder Yield	-6.96%
Earnings Yield	-21.42%
FCF Yield	-13.96%

Analyst Forecast

The average price target for TMCI is $7.00, which is 33.21% higher than the current price. The consensus rating is "Hold".

Price Target	$7.00
Price Target Difference	33.21%
Analyst Consensus	Hold
Analyst Count	6
Revenue Growth Forecast (5Y)	14.29%
EPS Growth Forecast (5Y)	-20.71%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TMCI has an Altman Z-Score of 3.57 and a Piotroski F-Score of 2.

Altman Z-Score	3.57
Piotroski F-Score	2